#USA #Boston #CMS #icotec #CMORE

icotec Secures CMS Approval for New Technology Payment

Icotec, a global leader in radiolucent implants designed for complex spinal surgeries, proudly announces an important achievement. As of October 1, 2026, the Centers for Medicare & Medicaid Services (CMS) approved a New Technology Add-On Payment (NTAP) for Icotec's CMORE® CT System. This decision marks a significant advancement in the accessibility of innovative spinal stabilization technologies for Medicare patients.

The CMORE® CT System, a posterior cervico-thoracic implant system, is specifically designed to support spinal stabilization while providing essential visualization for postoperative assessments. With the NTAP approval, eligible hospitals will be able to receive reimbursement for using this cutting-edge technology in treatments for Medicare beneficiaries.

Understanding the NTAP Program

The NTAP initiative by CMS was developed to facilitate the reimbursement process for hospitals that implement new technologies in their treatment frameworks. It enables hospitals treating patients with Medicare using the CMORE® CT System to obtain additional compensation, thereby fostering the integration of advanced medical solutions into clinical practice. This innovative product not only improves patient outcomes but also ensures that healthcare providers are financially supported in their efforts to adopt state-of-the-art technologies.

Christoph Eigenmann, CEO of Icotec USA, expressed excitement about the CMS's endorsement. “We are thrilled that CMS has acknowledged our CMORE® CT System under the NTAP program following its designation as a breakthrough device in April 2025,” Eigenmann stated. “With this new approval, clinicians now have access to an approved solution to offer their patients the CMORE® CT System, enabling enhanced visibility during surgical procedures through X-ray, CT imaging, and MRI.”

Innovative Features of CMORE® CT System

The CMORE® CT System is crafted using Icotec's proprietary BlackArmor® technology, showcasing both non-metallic and radiolucent properties. Constructed entirely from carbon/PEEK, it integrates polyaxial screws as well as straight and preformed rods that adapt to individual patient anatomies. This system is specially indicated for treating the majority of posterior cervico-thoracic conditions and is, notably, the only FDA-approved posterior cervico-thoracic system for spinal infection treatment.

By prioritizing innovative manufacturing techniques coupled with advanced material science, Icotec aims to provide spinal surgeons and their patients with reliable, cutting-edge solutions. The organization maintains collaborative relationships with clinicians to advance spinal implant technologies and positively shape the future of spinal surgery.

Looking Ahead

As the NTAP program is set to further support the adoption of Icotec's CMORE® CT System, healthcare professionals and hospital representatives are invited to learn more about the payment structure and its eligibility requirements. To facilitate inquiries, Icotec encourages direct contact at their dedicated support email for health professionals.

For additional details on Icotec and the CMORE® product line, interested parties can visit www.icotec-medical.com. This initiative represents yet another step toward enhancing patient care through innovative medical solutions.